Long-term results of Nivolumab + Cabozantinib in RCC

Published Date: 08 Mar 2023

The combination of first-line nivolumab and cabozantinib continues to outperform sunitinib in the treatment of patients with advanced renal cell carcinoma (RCC).

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How breast tissue density affects your risk of breast cancer

2.

CDC Alerts on Dramatic Rise in Human Parvovirus B19

3.

Big Drop in Cervical Cancer Deaths; Publication Hijackers; A Win for CRC Home Tests

4.

Resection for Early Liver Cancer Tied to Improved Survival.

5.

PSMA PET: Prostate Cancer Staging Revolution Awaits RCT Data


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot